An EDSS-based definition of secondary progressive multiple sclerosis

被引：0
|
作者：
Diaz-Cruz, C. [1 ]
Chua, A. S. [1 ]
Healy, B. C. [1 ,2 ]
Sattarnezhad, N. [1 ]
Glanz, B. I. [1 ]
Weiner, H. L. [1 ]
Chitnis, T. [1 ,3 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Partners Multiple Sclerosis Ctr, Boston, MA USA
[2] Massachusetts Gen Hosp, Biostat Ctr, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Partners Pediat Multiple Sclerosis Ctr, Boston, MA 02114 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P298
引用
下载
收藏
页码：107 / 108
页数：2
相关论文
共 50 条
  • [21] Imaging correlates of EDSS in Multiple Sclerosis
    Lima, C.
    Batista, S.
    d'Almeida, O. C.
    Macario, M. C.
    Santana, I.
    Sousa, L.
    Cunha, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 252 - 252
  • [22] Disability Accrual in Primary Progressive & Secondary Progressive Multiple Sclerosis
    Harding-Forrester, Sam
    Roos, Izanne
    Sharmin, Sifat
    Diouf, Ibrahima
    Malpas, Charles
    Nguyen, Ai-Lan
    Moradi, Nahid
    Horakova, Dana
    Havrdova, Eva Kubala
    Patti, Francesco
    Ayuso, Guillermo Izquierdo
    Madueno, Sara Eichau
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Onofrj, Marco
    Lugaresi, Alessandra
    Grand'Maison, Francois
    Weinstock-Guttman, Bianca
    Amato, Maria Pia
    Grammond, Pierre
    Gerlach, Oliver
    Ozakbas, Serkan
    Sola, Patrizia
    Ferraro, Diana
    Butzkueven, Helmut
    Lechner-Scott, Jeannette
    Boz, Cavit
    Alroughani, Raed
    Van Pesch, Vincent
    Cartechini, Elisabetta
    Terzi, Murat
    Maimone, Davide
    Ramo-Tello, Cristina
    Spitaleri, Daniele Litterio A.
    Kappos, Ludwig
    Yamout, Bassem
    Sa, Maria Jose
    Slee, Mark
    Morgado, Yolanda Blanco
    Bergamaschi, Roberto
    Butler, Ernest
    Iuliano, Gerardo
    Granella, Franco
    Sidhom, Youssef
    Gouider, Riadh
    Ampapa, Radek
    Van Wijmeersch, Bart
    Karabudak, Rana
    Prevost, Julie
    NEUROLOGY, 2021, 96 (15)
  • [23] Cognition in secondary progressive multiple sclerosis(SPMS)
    Doshi, A.
    De Angelis, F.
    Muhlert, N.
    Prados, F.
    Stutters, J.
    Macmanus, D.
    Wheeler-Kingshott, C. A. Gandini
    Cicarelli, O.
    Barkhof, F.
    Chataway, J.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 562 - 563
  • [24] Siponimod: A Review in Secondary Progressive Multiple Sclerosis
    Lesley J. Scott
    CNS Drugs, 2020, 34 : 1191 - 1200
  • [25] Prospects of siponimod in secondary progressive multiple sclerosis
    McGinley, Marisa
    Fox, Robert J.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
  • [26] Management of Secondary-Progressive Multiple Sclerosis
    Gavin Giovannoni
    CNS Drugs, 2004, 18 : 653 - 669
  • [27] Therapeutic approaches to secondary progressive multiple sclerosis
    Lublin, FD
    MULTIPLE SCLEROSIS, 2002, 8 (01): : 88 - 90
  • [28] Interferon beta for secondary progressive multiple sclerosis
    La Mantia, Loredana
    Vacchi, Laura
    Di Pietrantonj, Carlo
    Ebers, George
    Rovaris, Marco
    Fredrikson, Sten
    Filippini, Graziella
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (01):
  • [29] Immunopathology of secondary-progressive multiple sclerosis
    Prineas, JW
    Kwon, EE
    Cho, ES
    Sharer, LR
    Barnett, MH
    Oleszak, EL
    Hoffman, B
    Morgan, BP
    ANNALS OF NEUROLOGY, 2001, 50 (05) : 646 - 657
  • [30] Cognitive reserve in secondary progressive multiple sclerosis
    Sumowski, James F.
    Chiaravalloti, Nancy
    Leavitt, Victoria M.
    DeLuca, John
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (10) : 1454 - 1458
12345